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The use of bacteriophages (phages) for antibacterial therapy is
under increasing consideration to treat antimicrobial-resistant in-
fections. Phages have evolved multiple mechanisms to target their
bacterial hosts, such as high-affinity, environmentally hardy receptor-
binding proteins. However, traditional phage therapy suffers from
multiple challenges stemming from the use of an exponentially
replicating, evolving entity whose biology is not fully characterized
(e.g., potential gene transduction). To address this problem, we
conjugate the phages to gold nanorods, creating a reagent that can
be destroyed upon use (termed “phanorods”). Chimeric phages
were engineered to attach specifically to several Gram-negative or-
ganisms, including the human pathogens Escherichia coli, Pseudo-
monas aeruginosa, and Vibrio cholerae, and the plant pathogen
Xanthomonas campestris. The bioconjugated phanorods could se-
lectively target and kill specific bacterial cells using photothermal
ablation. Following excitation by near-infrared light, gold nanorods
release energy through nonradiative decay pathways, locally gen-
erating heat that efficiently kills targeted bacterial cells. Specificity
was highlighted in the context of a P. aeruginosa biofilm, in which
phanorod irradiation killed bacterial cells while causing minimal
damage to epithelial cells. Local temperature and viscosity measure-
ments revealed highly localized and selective ablation of the bacte-
ria. Irradiation of the phanorods also destroyed the phages,
preventing replication and reducing potential risks of traditional
phage therapy while enabling control over dosing. The phanorod
strategy integrates the highly evolved targeting strategies of
phages with the photothermal properties of gold nanorods, creat-
ing a well-controlled platform for systematic killing of bacterial cells.
bacteriophage | phage therapy | gold nanorods
Antibiotic-resistant bacterial infections, particularly fromGram-negative organisms, are widely recognized as an urgent threat
to health worldwide (1). The development of new antibacterial
agents targeting these organisms is therefore an important goal.
Phages have been long proposed as antibacterial agents, and recent
case studies (2, 3) and clinical trials (4) have prompted increased
attention. However, treatment of infection by whole phages pre-
sents critical challenges, such as a lack of biological characteriza-
tion of most phages, which may carry toxin genes or cause
generalized transduction of bacterial genes (5). An interesting
approach uses phages to deliver CRISPR-Cas cassettes as an-
timicrobials (6, 7), although this strategy faces challenges with ef-
ficient delivery to a wider range of bacterial targets (8). In addition,
the pharmacokinetics and pharmacodynamics of phages are diffi-
cult to model due to their exponential replication, presenting a
major barrier to clinical translation (9). Exponential replication
may also lead to undesirably rapid release of bacterial endotoxins
(10). A reductionist approach to avoid the problems associated
with whole phages is to engineer phage-derived proteins, such as
pyocins or lysins, as antibacterial agents (reviewed in ref. 11).
However, some advantages of whole phages, such as avidity of the
phage-displayed receptor-binding proteins (RBPs), which may
increase affinity by ∼1,000× compared to recombinant RBP (12),
interaction with secondary receptors on the bacterial host (13, 14),
and subdiffusive search mechanisms (15, 16), may be lost.
Therefore, an alternative approach is to utilize the phage for
bacterial attachment, and then destroy the phages simultaneously
with the bacteria, thus controlling dosage and avoiding undesired
consequences while maintaining the advantages of whole phage as
a delivery vehicle.
Here, we use photothermal heating as a physical mechanism
that would result in both phage and host cell destruction, which
can be achieved using metallic nanomaterials (17–22). These
nanostructures, such as gold nanorods (AuNRs), exhibit a lo-
calized surface plasmon resonance (LSPR) upon irradiation with
light, which induces coherent oscillation of the electron cloud.
This energy can be released primarily as heat, leading to high
local temperatures (e.g., ΔT up to ∼50 °C, depending on the
laser power applied) with a half-length in the submicron range
(from a single nanoparticle) to a few microns (from an ensemble
of nanoparticles) (23, 24), potentially killing nearby bacterial or
eukaryotic cells. The LSPR spectrum of AuNRs can be tuned by
their size, allowing excitation by light in the near-infrared (NIR)
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“biological window” for which soft tissues are somewhat trans-
parent. Other nanomaterials also exhibit nonspecific cytotoxic
properties (e.g., nanosilver) through a variety of chemical mech-
anisms, but a general problem with the application of nano-
materials against bacterial infections is their lack of specificity
against bacterial vs. mammalian cells, presenting a general chal-
lenge for biocompatibility (25).
To confer specificity to nanostructures, one may conjugate
antibodies that target specific bacterial strains (26), following
upon extensive work targeting nanoparticles for cancer cell
treatment (27–30). However, phage-based strategies possess
several advantages compared to antibody-based strategies. First,
greater delivery of nanoparticles per bacterial receptor could be
achieved using phages due to the comparatively large surface
area of phage, which may accommodate multiple nanoparticles;
this property could be useful if bacterial receptors are in low
abundance. A related benefit is that the aggregation of nano-
particles with phages on bacteria produces a visible shift in the
LSPR spectrum (31), and one might therefore envision appli-
cations that combine treatment and detection of bacteria. Sec-
ond, in addition to the targeting mechanisms evolved by whole
phages as described above, chimeric phages can be rationally
designed to achieve specificity against different bacterial hosts
(8). This potential is largely untapped, as there exists a mostly
uncharacterized biological reservoir of phages that could pre-
sumably target many different bacterial strains (32). While phages
are well known for their host specificity, a number are broad in
host range (33), suggesting that the degree of specificity could be
tuned depending on the desired application. Third, in practical
terms, phages are inexpensive to produce and have typically
evolved some hardiness to nonideal environmental conditions.
These features make phage-based nanotechnology attractive for
biotechnological and biomedical applications.
In this work, we investigated the ability of phage–AuNR bio-
conjugates (phage–AuNRs; Fig. 1A) to specifically attach to and
then kill targeted bacterial cells via the photothermal effect. In
this scheme, the phage confers specific targeting while the AuNRs
achieve the desired effect. Using chimeric phages we previously
engineered (31) to target several bacterial pathogens (two strains
of Escherichia coli, Pseudomonas aeruginosa, Vibrio cholerae, and
two strains of the plant pathogen Xanthomonas campestris), we
first show that the phage–AuNRs can be used to detect specific
bacteria through phage-mediated aggregation of AuNRs on the
bacterial surface, which causes a red shift of the longitudinal
LSPR peak. Next, we use NIR irradiation to induce death of the
targeted bacteria via photothermal heating, both in solution and in
a P. aeruginosa biofilm grown on a substrate of mammalian epi-
thelial cells. Photothermal lysis was highly selective and resulted in
extensive killing of targeted bacteria within minutes, with low rates
of damage to nontarget bacteria and mammalian cells (Fig. 1B).
After photothermal lysis, the phages are no longer capable of
replication, allowing control over dosage in principle. The po-
tential of phage–AuNRs for treatment and diagnosis of antibiotic-
resistant bacterial infections is discussed.
Results
Construction of Phage–AuNR Bioconjugates. The AuNRs were syn-
thesized following a typical seed-mediated protocol (34), resulting
in uniform particles with an average aspect ratio of 3.8 (average
length, 53.2 nm; average width, 13.7 nm; SI Appendix, Fig. S1A).
The UV-vis spectrum of the AuNRs demonstrated transverse and
longitudinal absorption peaks at 526 and 800 nm (35), respectively
(SI Appendix, Fig. S1B). The capsid of M13KE phage was modified
with SATP to introduce thiol groups to primary amines. Thiolation
resulted in new signals by Fourier-transform infrared (FTIR)
spectroscopy (SI Appendix, Fig. S2A), indicating successful modi-
fication of the virions, designated M13KE-SH. The overall mor-
phology of the phage, assessed by transmission electron microscopy
(TEM), was not affected by thiolation (SI Appendix, Fig. S2 B
and C).
Surface modification of gold nanostructures under aqueous
conditions has been widely reported (36–38). M13KE-SH was
conjugated to AuNRs by formation of gold–sulfur bonds at room
temperature in Tris buffer (pH 3.0) (39). Interaction between
Fig. 1. Schematic of phage–AuNR bioconjugates for bacterial detection and cell killing. (A) Filamentous phage M13 (gray) was engineered to express the
receptor-binding protein from a foreign phage (blue) fused to wild-type g3p to obtain retargeted chimeric phage. Chemical modification by N-succinimidyl-S-
acetylthiopropionate (SATP) introduced thiol groups (yellow) along the phage coat, and gold nanorods (AuNRs) were conjugated to the phage via thiol–gold
bonds. (B) Phage–AuNR bioconjugates recognize specific bacteria (blue) in the context of mammalian cells and other nontarget bacteria (green). Attachment
of phage triggers AuNR aggregation on the cell surface, resulting in a red-shifted LSPR spectrum (indicated as magenta nanorods) for bacterial detection.
Exposure to NIR light induces photothermal heating of AuNRs, leading to highly elevated temperatures localized by the phage, resulting in death of the
targeted bacteria.
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AuNRs and phages during bioconjugation was promoted by the
positive charge from trace CTAB on the AuNRs (ζ = 21.9 mV)
and the negatively charged capsid protein of phage particles
(ζ = −44.3 mV). The formation of Au–S bonds in the bio-
conjugates was confirmed by X-ray photoelectron spectroscopy
(XPS) (SI Appendix, Fig. S1 C and D). Trace CTAB was then
replaced by ligand exchange with carboxylated PEG (HS-PEG-
COOH) after bioconjugation. Formation of bioconjugates was
also confirmed by TEM (Fig. 2A), which indicated ∼10 AuNRs
per phage. Another approach to estimate the ratio of AuNRs to
phage particles is inductively coupled plasma mass spectrometry
(ICP-MS) to measure the amount of AuNRs and qPCR to
measure the amount of phage in a sample; this approach in-
dicated ∼20 AuNRs per phage. Thus, an estimate of the number
of AuNRs conjugated per phage particle is roughly 15.
The UV-vis spectrum of the bioconjugates indicates a red shift
of ∼10 nm compared to AuNRs alone (SI Appendix, Fig. S1B).
The negatively charged surface of HS-PEG-COOH–modified
M13KE–AuNR (ζ = −28.8 mV) should reduce nonspecific
binding to bacteria considering the negatively charged cell sur-
face (ζ = −8.88 mV). TEM demonstrated that while HS-PEG-
COOH–modified AuNRs do not attach to E. coli cells in the
presence of nonconjugated M13KE (Fig. 2B), phage–AuNRs
attach to E. coli cells (Fig. 2C), as expected. To further confirm
that the M13KE–AuNR bioconjugates retain the ability to in-
teract with E. coli, M13KE–AuNRs were labeled with a fluo-
rescent dye using fluorescein-5-maleimide (FITC) through
thiol-maleimide click chemistry, as M13KE–AuNRs contained
free thiols according to the XPS spectrum (SI Appendix, Fig. S1D).
The FITC-labeled M13KE–AuNRs were incubated with E. coli
expressing a cyan fluorescent protein (12) and visualized by con-
focal microscopy, which verified close proximity of FITC and cyan
fluorescence (SI Appendix, Fig. S3).
Having verified the method with M13KE, AuNR bioconjugates
were also prepared with chimeric phages M13-g3p(If1), M13-
g3p(Pf1), M13-g3p(ϕLf), M13-g3p(ϕXv), and M13-g3p(CTXϕ),
targeting E. coli (I+), P. aeruginosa, X. campestris pv. campestris,
X. campestris pv. vesicatoria, and V. cholerae, respectively (31)
(Table 1).
Detection of Specific Bacterial Species by Phage–AuNRs. We pre-
viously reported a detection method for specific bacterial species
using thiolated phages to target aggregation of gold nanospheres
(AuNPs), which causes a red shift of LSPR peaks in the UV-vis
spectrum (31). In this prior work, abundant thiol groups were
incorporated on carboxylates of the phage capsid (with three or
more solvent-accessible residues on each g8p protein) to induce
aggregation of gold nanoparticles, and removal of free thiolated
phage was required to remove background signal. In the present
work, we reduced the level of thiolation of the phage surface by
using amines for bioconjugation, of which there is only one
solvent-accessible residue (at the N terminus) of each g8p (28).
The phage–AuNRs synthesized here did not aggregate detect-
ably in the absence of cells, but aggregation and the associated
broadening and red shift of the absorbance spectrum were ob-
served upon attachment to the target cells (Figs. 2C and 3A and
SI Appendix, Figs. S1B and S4 and Text S1), simplifying the
detection protocol to single-step addition of the bioconjugates to
the cell sample in appropriate solution. E. coli ER2738 was
suspended at varying concentrations in MilliQ water and in-
cubated with M13KE–AuNRs for 30 min. Consistent with prior
results using AuNPs, a red shift and broadening of LSPR peaks
of the AuNRs were observed in the presence of ≥102 bacterial
cells (SI Appendix, Fig. S1B), demonstrating the sensitivity of
bacterial detection using phage–AuNRs.
Five chimeric phages recognizing other Gram-negative bac-
terial strains (I+ E. coli, P. aeruginosa, V. cholerae, and two strains
of X. campestris) were propagated in E. coli cells, as previously
described (31), and functionalized with AuNRs, as described
above. As seen with M13KE–AuNRs targeting E. coli (SI Ap-
pendix, Fig. S1B), the sensitivity of detection for these other
strains was ∼102 CFU using the respective chimeric phage–
AuNRs (Fig. 3A and SI Appendix, Fig. S4).
To verify the specificity of each of the six phage–AuNRs for its
respective host, we incubated each phage–AuNR with the other
bacterial strains. For each phage–AuNR, no shift or broadening
of the LSPR peaks appeared when nonhost strains were added
(Fig. 3B and SI Appendix, Fig. S5), indicating little cross-
reactivity among the tested group of Gram-negative organisms.
The detection assay was also performed in a mixture of the host
strains, and no change of the LSPR peaks was observed unless
the heterogeneous mixture contained the targeted host cells (Fig.
3C and SI Appendix, Fig. S6). These results confirm the ability of
the chimeric phages to target the AuNRs to their particular
bacterial host.
Photothermal Ablation of Bacterial Cells in Suspension. The plas-
monic resonance of AuNRs converts light into heat, which can
be used to damage and kill cells within a submicrometer to mi-
crometer radius (40). Samples containing AuNRs or phage–
AuNRs or neither were irradiated by a NIR laser (peak at 808 nm)
for 10 min, and the bulk temperature of the solution was mea-
sured by a thermocouple (SI Appendix, Fig. S7A). In a control
sample of water without AuNRs or phage–AuNRs, some heating
(from 24 to 37 °C) occurred from the laser alone. However, all
solutions containing AuNRs [AuNRs (equivalent to 3.3 nM
AuNRs), M13KE–AuNRs (equivalent to 3.3 nM AuNRs and
1011 phages per mL), or M13KE–AuNRs mixed with E. coli
Fig. 2. Interaction between M13KE, AuNR, and E. coli cells. TEM image of M13KE–AuNR (A) illustrates conjugation of filamentous phage and AuNRs. When
E. coli cells were mixed with M13KE and HOOC-PEG–AuNR (nonconjugated), no aggregation or localization of AuNRs to the cells was seen (B), but HS-PEG-
COOH-modified M13KE–AuNR bioconjugates attached to E. coli cells did result in visible aggregation of AuNRs on the cell surface (C). Aggregation at one end
of the bacterium (in C) presumably occurs near the position of the F pilus; stimulation of retraction by phage attachment may cause accumulation at the root
of the pilus (57, 58).
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ER2738 (106 cells per mL)] reached bulk temperatures of 77 to
81 °C. A sample containing M13KE–AuNRs alone reached
81 °C, while a sample containing M13KE–AuNR mixed with E. coli
reached a lower temperature (77 °C). This slight reduction is
expected due to the aggregation of M13KE–AuNRs on the cells
(see preceding section). That is, since aggregation leads to a
broadened and red-shifted LSPR peak, absorption at the laser
wavelength (808 nm) is reduced (SI Appendix, Fig. S7B) and
leads to slightly less efficient heating when phage–AuNRs are
aggregated on the target cells. Plating of samples containing
M13KE–AuNRs mixed with E. coli ER2738 and irradiated
demonstrated that roughly 50% of bacteria were killed by 3 min,
∼80% of bacteria were killed by 6 min, and no viable bacteria
remained after 10 min (Fig. 4 A and C). Similar results were
observed using all six phage–AuNR bioconjugates to kill their
respective host bacterial cells (Fig. 4 B and C and SI Appendix,
Fig. S8). TEM imaging of M13KE–AuNRs mixed with E. coli
ER2738 cells and irradiated demonstrated grossly altered cell
morphology (SI Appendix, Fig. S9A). A live/dead cell-staining
assay further verified >99% bacterial cell death after 10 min of
irradiation by microscopy (SI Appendix, Fig. S10).
In principle, cell death should occur primarily for the targeted
host organism bound by the phage–AuNRs. However, nontargeted
cells may also die as the temperature of the bulk solution increases
or if they are bound nonspecifically by phage–AuNRs. As expec-
ted, irradiation of bacteria with nonconjugated AuNRs resulted in
gradual cell death (SI Appendix, Fig. S11), presumably from bulk
heating of the solution by irradiated AuNRs, and this rate of cell
death was substantially slower than the rate of death using targeted
phage–AuNRs (Fig. 4C). Irradiated bacteria (without AuNRs)
showed no significant cell death compared to nonirradiated bac-
teria, indicating that irradiation alone is not toxic (SI Appendix, Fig.
S12). To test the efficiency and specificity of bacterial cell death in
the context of a bacterial mixture, F+ E. coli cells (ER2738; host for
M13KE) that express cyan fluorescent protein (106 cells per mL)
were mixed with F− E. coli cells (BL21; lacks receptor for M13KE)
that express citrine fluorescent protein (106 cells per mL), in-
cubated with M13KE–AuNRs (1011 phages per mL), and irradi-
ated to induce photothermal lysis (12). Samples were plated and
viable colonies were counted. The concentration of F+ E. coli
(targeted strain) decreased sharply, with no colony-forming units at
10 min (Fig. 4D and SI Appendix, Fig. S13). In contrast, the con-
centration of F− E. coli (nontarget strain) changed only slightly
compared to control (Fig. 4D and SI Appendix, Fig. S13). This
confirms that the phage–AuNRs distinguished bacterial strains as
expected and selectively killed the targeted cells.
While the bulk temperature increases upon irradiation, bind-
ing of phage–AuNRs to bacterial cells should induce localized
heating of the cell. To estimate the temperature of the bacteria,
E. coli ER2738 were stained with the temperature- and pH-
sensitive dye BCECF, whose fluorescence intensity decreases
linearly with temperature (SI Appendix, Fig. S9 B and C). The
steady-state fluorescence intensity of BCECF was recorded during
irradiation of E. coli ER2738 with M13KE–AuNRs. The apparent
cell temperature reached a plateau of ∼83 °C after 3 min and rose
more quickly than the bulk temperature, being higher than the
bulk temperature at all observed time points. The temperature
gap between cell temperature and bulk temperature (measured by
thermocouple) was observed to be ∼13 °C at 3 min (SI Appendix,
Fig. S9D). It should be noted that bulk heating observed depends
on the concentration of AuNRs as well as heat dissipation prop-
erties of the medium and cuvette. The BCECF measurement is
also likely to underestimate the true bacterial cell temperature
since some dye is also dissolved in the bulk; thus, it should be
Fig. 3. Detection of P. aeruginosa. (A) UV-vis spectra of AuNR (black), phage–AuNR (red), and phage–AuNR with P. aeruginosa at 102, 104, and 106 CFU (blue,
magenta, and green lines, respectively) are shown; (B) Specificity of P. aeruginosa detection when incubated with different bacterial species (106 CFU). Bacterial
species shown are E. coli (F+) (blue), V. cholerae (magenta), X. campestris (pv campestris) (green), X. campestris (pv vesicatoria) (navy), E. coli (I+) (cyan), and P.
aeruginosa (purple). (C) Sensitivity of P. aeruginosa detection in the context of a mixture of bacteria [E. coli (F+), V. cholera, X. campestris (pv vesicatoria), X.
campestris (pv campestris), and E. coli (I+)]. The target cells P. aeruginosawere present in the amount indicated in the legend [102 (blue), 104 (magenta), 106 (green)
CFU]; the other bacterial species were present at 106 CFU each. The spectra of AuNRs (black) and M13-g3p(Pf1)–AuNR bioconjugates (red) are also shown.
Table 1. Chimeric phage bioconjugates and targeted bacterial species
Bacterial target strain Source of RBP Designation of bioconjugates
E. coli (F+), ER2738 Wild-type M13 M13KE–AuNR
V. cholerae 0395 CTXϕ M13-g3p(CTXϕ)–AuNR
E. coli (I+), (Migula) Castellani and Chalmers If1 M13-g3p(If1)–AuNR
X. campestris (pv. campestris) ϕLf M13-g3p(ϕLf)–AuNR
X. campestris (pv. vesicatoria) ϕXv M13-g3p(ϕXv)–AuNR
P. aeruginosa (Schroeter) Migula Pf1 M13-g3p(Pf1)–AuNR
See ref. 31 for additional details.
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regarded as a lower bound for bacterial cell temperature. In
addition, pH is assumed to be constant during irradiation, such
that the fluorescence change is attributed to temperature changes.
Nevertheless, this measurement validates the qualitative expecta-
tion that the targeted cells are heated beyond the level of the
bulk solution.
Photothermal Ablation of P. aeruginosa in Biofilms. Biofilms present
an important obstacle to antibiotics and other therapeutic
strategies due to the dense macromolecular network and altered
physiological state of the biofilm cells. To determine whether
photothermal ablation could be effective against bacterial bio-
films, we grew P. aeruginosa in a standard biofilm format on
glass-bottom plates (41), incubated the biofilm with M13-
g3p(Pf1)–AuNRs (1013 phages per mL), removed excess liquid
by pipetting, and irradiated as described above for 10 min. Live/
dead staining of the biofilm showed widespread bacterial cell
death (Fig. 5 A and B). The green dye SYTO 9 enters both live
and dead cells, while the red dye propidium iodide (PI) only
enters compromised cell membranes (dead cells). Object-based
colocalization analysis was used to determine the fraction of cells
(green) that also stained red; this analysis confirmed extensive
cell death (Fig. 5 A and B and SI Appendix, Fig. S14). In addition,
no colonies were obtained after resuspension and plating of the
irradiated biofilm (SI Appendix, Fig. S15), indicating that no vi-
able cells remained. The extent of cell death during irradiation
was also quantified by the PrestoBlue cell viability assay, which
confirmed that viable cells were undetectable after 10 min of
irradiation (Fig. 5C).
To assess the effectiveness of phage–AuNRs against more
mature biofilms, we grew P. aeruginosa biofilms for longer times
(24 and 48 h), resulting in increased extracellular polymeric
substance (EPS) formation verified by crystal violet staining (SI
Appendix, Fig. S16). Cell killing was slightly slower for more
mature biofilms, but still there was no detectable viability after
10 min of irradiation (Fig. 5C).
To gain a rough estimate of the temperature of the biofilm
after NIR irradiation, the biofilms were stained with BCECF. To
create a calibration curve, a series of fluorescent images was
recorded at different temperatures using a confocal microscope
(SI Appendix, Fig. S17A), and the pixel intensity (measured by
ImageJ) was plotted as a function of temperature (SI Appendix,
Fig. S17B). The average bacterial cell temperature captured a
few seconds after 10 min of NIR irradiation was estimated to be
84 °C using this calibration curve (SI Appendix, Fig. S17C), in-
dicating similarly efficient heat transfer from the AuNRs to
bacterial cells in the biofilm compared to solution.
Photothermal Ablation of P. aeruginosa Biofilm Grown on Mammalian
Epithelial Cells. While phage–AuNR-mediated heating was ef-
fective for killing bacterial cells, it is possible that heat transfer to
surrounding mammalian cells could be deleterious. We grew a P.
aeruginosa biofilm directly on top of a monolayer of Madin-
Darby Canine Kidney II (MDCKII) mammalian epithelial cells
(42) and determined the survival of both the bacterial cells and
the MDCKII cells after application of M13-g3p(Pf1)–AuNRs
with irradiation performed as described above. Microscopy with
live/dead staining demonstrated that bacterial cells in the biofilm
were killed while MDCKII cells survived, with extensive (∼98%)
Fig. 4. Photographs of (A) E. coli (F+) ER2738 and (B) P. aeruginosa plated on LB plates after different NIR irradiation times; C and D show loss of colony-
forming units at different irradiation time points (normalized to a control with bacteria mixed with nonconjugated AuNRs and irradiated for the same time; SI
Appendix, Fig. S11). Error bars show 1 SD calculated from three or more replicates. Absence of visible error bars indicates no deviation among sample
measurements (0 colonies).
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bacterial cell death by 10 min (Fig. 6 and SI Appendix, Figs. S18
and S19). This result was verified by a PrestoBlue cell viability
assay (Fig. 7A), which indicated that nearly all bacterial cells were
killed by incubation with M13-g3p(Pf1)–AuNRs and 10 min of
irradiation at the laser power used (3.0 W/cm2). The viability of
MDCKII cells without biofilm was reduced to ∼71% by applica-
tion of M13-g3p(Pf1)–AuNRs and irradiation for 10 min, com-
pared to MDCKII cells before exposure to M13-g3p(Pf1)–AuNRs
or irradiation (Fig. 7A, blue line). Interestingly, when the MDCKII
cells were covered by a P. aeruginosa biofilm, a greater proportion
of the MDCKII cells appeared to survive application of M13-
g3p(Pf1)–AuNRs and irradiation for 10 min (∼84% viability; Fig.
7A, red line), as determined by PrestoBlue assay. The fluorescence
of the MDCKII cells covered by biofilm, treated, and irradiated
for 10 min, could be attributed to the MDCKII cells because
negligible fluorescence intensity was observed for an identically
treated and irradiated bacterial biofilm without MDCKII cells
(Fig. 7A, black line). This protective effect could be due to the
biofilm adsorbing the M13-g3p(Pf1)–AuNRs, leading to less
nonspecific binding of the bioconjugates to MDCKII cells and/or
to a reduction of laser fluence reaching the MDCKII cells due to
absorption by the greater number of bioconjugates in the biofilm.
Regardless, these results demonstrated survival of the majority of
mammalian cells while few (if any) bacterial cells survived; opti-
mization of the irradiation protocol may enhance this difference.
Furthermore, the phages and bioconjugates themselves (without
irradiation) were nontoxic to MDCKII cells in a broad concen-
tration range, as demonstrated by the PrestoBlue cell viability
assay (Fig. 7B).
To further probe the effect of phage–AuNRs on the bacteria
andMDCKII cells, we characterized the viscosity of cell membranes
using a molecular rotor, a dye whose fluorescence lifetime provides
a measurement of local microviscosity. The viscosity of the cell
membrane is expected to decrease upon intense heating, leading
to destruction of membrane order. We stained the MDCKII/
P. aeruginosa biofilm with the molecular rotor BODIPY C10 and
used fluorescence lifetime imaging (FLIM) (43) to assess mem-
brane viscosities after photothermal treatment (Fig. 8 and SI
Appendix, Fig. S20). While the MDCKII cells did not exhibit
substantial change in fluorescence lifetime after irradiation (2.31 ±
0.17 ns before irradiation; 2.23 ± 0.21 ns after irradiation), the
fluorescence lifetime of the dye on P. aeruginosa cells decreased
from an average of 2.36 ± 0.12 to 0.92 ± 0.09 ns, corresponding
to a dramatic drop in viscosity from 296 to 38 cP (see Eq. 1). This
finding is consistent with the idea that the phage–AuNRs directly
target the bacterial host cells with relatively little damage to
other cells.
To verify whether NIR irradiation destroyed the infectious
potential of the phages, M13KE–AuNRs were irradiated for
10 min and then used to infect E. coli for phage propagation.
Putative viral DNA was extracted and assayed by qPCR (31). No
DNA was detected from propagation of the treated sample (SI
Appendix, Fig. S21), confirming that the phages were inactivated
during the treatment.
Comparison to AuNRs Conjugated to Anti-LPS Antibodies. The opti-
cal and cell-killing properties of M13KE–AuNRs were com-
pared to those of AuNRs conjugated to a commercially available
monoclonal antibody against the lipopolysaccharide (LPS) of E.
coli (αLPS–AuNRs; SI Appendix, Methods). In these experi-
ments, the concentration of AuNRs was kept constant between
samples with M13KE–AuNRs and samples with αLPS–AuNRs.
Attachment of αLPS–AuNRs to E. coli was verified by TEM
(SI Appendix, Fig. S22 A and B). During photothermal ablation
in solution, αLPS–AuNRs killed cells significantly more slowly
than M13KE–AuNRs (50% of cells killed after ∼6 min of ir-
radiation for αLPS–AuNRs compared to <3 min for M13KE–
AuNRs) (SI Appendix, Fig. S23A). The cell-killing activity of
the conjugates against target cells in the context of a large
excess of nontarget cells was also compared for M13KE–AuNRs
vs. αLPS–AuNRs. We mixed F+ E. coli (target) with F− E. coli
(nontarget) in a frequency of 10−6. In the mixture, irradiation
with M13KE–AuNRs eradicated the F+ cells (no detected
colonies) while leaving most F− cells alive, as expected. How-
ever, αLPS–AuNRs, which are not expected to discriminate
between F+ and F− cells, indeed killed both types of cells to the
same degree. Moreover, αLPS–AuNRs were not able to erad-
icate either cell type, with ∼30% of cells surviving (SI Appendix,
Fig. S23B).
The LSPR spectral shift was also compared for αLPS–AuNRs
vs. M13KE–AuNRs. αLPS–AuNRs show a spectral shift with a
similar limit of detection (LOD ∼ 102 CFU) as M13KE–AuNRs
at neutral pH (SI Appendix, Fig. S22). However, M13KE–AuNRs
tolerated both acidic and alkaline conditions (pH 3 and pH 10),
but the LOD of αLPS–AuNRs increased by 4 orders of magni-
tude under these conditions. In addition, M13KE–AuNRs tol-
erated heat treatment (60 °C for 15 min) while αLPS–AuNRs did
Fig. 5. Treatment of P. aeruginosa biofilm by M13-g3p(Pf1)–AuNRs and NIR
irradiation. Live/dead cell staining assay of P. aeruginosa biofilm (A) before
and (B) after 10-min irradiation. From Left to Right are green field (SYTO 9:
all cells) and red field (PI: dead cells). fcol is the fraction of cells identified as
dead, = Ncol/Ngreen, where Ngreen is the number of green objects counted and
Ncol is the number of green objects whose centers colocalize with the center
of a red object (JACoP, version 2.0/ImageJ). Also see SI Appendix, Fig. S14.
(Scale bar: 30 μm.) (C) PrestoBlue cell viability results for biofilms grown for
12 to 48 h (fluorescence indicates reducing potential and thus quantity of
living cells). Fluorescence was normalized by the average initial fluorescence
of the samples before irradiation; the control is MilliQ water.
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not (LOD increased by 2 orders of magnitude). In acidic and
alkaline (pH 3 and pH 10) conditions, cell killing by M13KE–
AuNRs was maintained at high efficiency while αLPS–AuNRs
lost activity (SI Appendix, Fig. S23A). These observations are
consistent with the fact that many factors (e.g., temperature, pH,
ionic strength, growth media) can disrupt the antigen–antibody
interaction (44–46), while phage–host interactions appear to be
more robust to environmental factors.
Discussion
We present an antibacterial strategy using phages conjugated to
AuNRs (phage–AuNRs, referred to in the following discussion
as “phanorods,” a portmanteau of “phage” and “nanorods”). The
phages attach to targeted bacteria, and irradiation of the nanorods
by NIR light causes LSPR excitation. This energy is released as
heat, destroying the phage as well as bacteria bound to the phage.
The phanorod strategy has important advantages over traditional
approaches to phage therapy. First, phage therapy suffers from the
major difficulty of managing a replicating and evolvable entity.
While the evolutionary capacity of phages is advantageous for
overcoming bacterial resistance against a phage, evolutionary
potential is an important biocontainment concern in practice.
Second, nonlinear replication dynamics mean that dosages cannot
be easily controlled, which may be problematic if cell lysis releases
endotoxins triggering deleterious host responses (e.g., septic
shock). Phanorods are destroyed during irradiation, preventing
replication and evolution during treatment and enabling control
over dosage. Irradiation could also be used to inactivate excess
phanorods after use, avoiding negative impacts, such as evolution
of resistant organisms, currently associated with antibiotics in
the waste stream. Third, evolution of resistance is an important
challenge for any antibacterial strategy, including phanorods.
However, because the phage is used only for attachment to cells
and downstream events (e.g., replication) are not relevant, bac-
terial mechanisms for resistance should be limited to alterations of
the receptor, presenting a smaller mutational target for evolution
of resistance. Fourth, phanorods serve simultaneously as diagnosis
and cytotoxic reagents, as the change in the LSPR spectrum can
be used to recognize bacterial species. Therefore, although there
may be situations in which therapy with phages per se is desired
(e.g., if exponential replication dynamics are needed), phanorod
pharmacokinetics and pharmacodynamics may more closely re-
semble those of a typical drug rather than a living organism, which
would be advantageous for most therapeutic situations.
Conversely, one may consider how phanorods compare to
antibody-conjugated nanorods. In addition to unique search mech-
anisms (see Introduction), phages can possess very high affinities
Fig. 6. Live/dead cell staining assay of P. aeruginosa biofilm grown on
MDCKII cells, treated with M13-g3p(Pf1)–AuNRs, before (row A) and after
(row B) 10 min of NIR irradiation. From Left to Right are green field (SYTO 9:
all cells) and red field (PI: dead cells). See Fig. 5 for explanation of Ngreen, Ncol,
and fcol. In B, because stained MDCKII nuclei interfered with object detection,
two regions were chosen from the larger image, which avoided overlap with
MDCKII nuclei. Counts are given for both regions. Also see SI Appendix, Fig.
S18. (Scale bar: 30 μm.)
Fig. 7. Treatment of P. aeruginosa biofilm grown on MDCKII cells using M13-g3p(Pf1)–AuNRs and biocompatibility of phage–AuNRs with MDCKII cells. (A)
PrestoBlue cell viability assay results for M13-g3p(Pf1)–AuNR treatment and irradiation of MDCKII cells grown alone (blue), M13-g3p(Pf1)–AuNR treatment
and irradiation of P. aeruginosa biofilm grown on MDCKII cells (red), and M13-g3p(Pf1)–AuNR treatment and irradiation of P. aeruginosa biofilm alone
(grown without MDCKII cells; black), over time during irradiation. The control (magenta) is MilliQ water alone. In this assay, the PrestoBlue reagent is
modified by the reducing environment of live cells and becomes fluorescent; both MDCKII and P. aeruginosa cells contribute to PrestoBlue fluorescence.
MDCKII cells (blue) are largely viable upon M13-g3p(Pf1)–AuNR treatment and irradiation, while P. aeruginosa cells (black) are killed by M13-g3p(Pf1)–AuNR
treatment and irradiation over the time course shown. As expected, the PrestoBlue fluorescence of the biofilm grown on MDCKII cells during M13-g3p(Pf1)–
AuNR treatment and irradiation (red) is roughly equal to the sum of the fluorescence of MDCKII cells treated and irradiated alone (blue) plus the fluorescence
of biofilm cells treated and irradiated alone (black). After 6 min of treatment and irradiation, the fluorescence of the biofilm grown on MDCKII cells (red)
appears to be similar to that of MDCKII cells alone (treated and irradiated; blue), consistent with selective killing of P. aeruginosa. (B) Biocompatibility of
phage–AuNRs was measured by PrestoBlue cell viability assay. M13KE–AuNRs or M13KE phages at different concentrations were incubated with MDCKII cells
for 48 h without irradiation. The control is MDCKII cells alone (without M13KE–AuNRs or M13KE). Cell viability percentages were calculated by normalizing
fluorescence intensity by the control fluorescence. The concentration of the bioconjugates and phages are given in units of micromolar concentration
(1 μM ∼ 6 × 1014 phage particles per mL). Error bars represent 1 SD calculated from triplicates.
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to their targets. For example, the affinity of M13KE for F+ E. coli
is 2 pM (12), which is several orders of magnitude greater than the
affinities of antibodies reported against F pilin (47) and also
higher than affinities of most antibodies isolated from mice (30 to
500 pM, with those at low picomolar affinity being quite rare) (48,
49). In the experimental comparison done here between M13KE–
AuNRs and αLPS–AuNRs, we found that M13KE–AuNRs in-
deed outperformed αLPS–AuNRs in photothermal ablation ex-
periments, despite the greater amount of LPS present on the cell
surface compared to the F pilus. It may be of particular interest to
eradicate targeted bacteria in small numbers, such as “persister”
cell populations that escape other treatment modalities (50). In
such applications, the very high affinities and often high specific-
ities of phages would avoid competition for binding by nontarget
cells and thus prevent loss of phanorod activity compared to
αLPS–AuNRs, as demonstrated here in a mixed bacterial pop-
ulation. The experiments also confirmed the environmental har-
diness of the phanorods, which, unlike the αLPS–AuNRs, tolerated
the range of pH tested (pH 3 to 10) as well as heat treatment. We
speculate that very high affinities and “hunting” strategies for
bacteria, environmental hardiness, and tolerance to mutations and
thus chemical modification, which characterize phages, are traits
under selection by the ongoing evolutionary “arms race” between
bacteria and phages (51). This constellation of traits is advanta-
geous for therapeutic nanomaterials and may be unique to phages.
The phanorod strategy presented here is best suited for treat-
ment of directly accessible tissues or surfaces. Near-term appli-
cations could be localized topical therapy, particularly for wound
infections or colonization of medical devices, in which the phage–
nanorods can be directly applied to the biofilm. For example,
while P. aeruginosa is well known as a pulmonary pathogen, drug-
resistant P. aeruginosa is also a major pathogen in chronic wounds
(52), surgical site infections, and burns (53). Such wounds would
be directly accessible for application of therapeutic nanomaterials
and NIR irradiation.
Bacterial biofilms represent a difficult challenge (54) for treat-
ment, as the protective extracellular matrix often inhibits access by
antibiotics. However, heat can be transferred without molecular
penetration into the biofilm. While the phanorod strategy should
be generalizable to different bacterial strains depending on the
creation of chimeric phages, we focused on P. aeruginosa as one
of three “critical priority” bacterial pathogens identified by the
World Health Organization (55). In this work, we demonstrated
that phanorods were effective in killing a P. aeruginosa biofilm
grown on epithelial cell culture (see SI Appendix, Text S2 for
further discussion). Some photothermal damage was incurred by
epithelial cells, although the viability measured here is likely a
lower bound since the biofilm was in direct contact with the
monolayer; underlying cellular layers in a physiological context
would likely sustain less damage. The phanorods used here absorb
in the relatively biologically transparent window of NIR light. In
principle, irradiation could be directed only toward areas where
activation of the phanorods is desired, reducing potential side
effects. Whether iterative phanorod application could be effective
in treating thicker and deeper biofilms (e.g., abscesses) without
substantial harm to surrounding tissue is an important practical
issue. In addition, while excess phanorods could be removed by
washing for certain wounds, a consideration for other applications
is the in vivo biodistribution of phanorods in the absence of target
bacteria. Nevertheless, phanorods and other alternative strategies
merit consideration given the current need to develop new
antibiotic agents.
Methods
Materials. Reagents were obtained from the following sources: gold(III)
chloride trihydrate (HAuCl3•3H2O) (99.9%; Sigma), sodium borohydride (NaBH4)
(98%; Fisher Scientific), trisodium citrate dihydrate (99.9%; Sigma), Escherichia
coli (Migula) Castellani and Chalmers (ATCC27065, ATCC), E. coli ER2738 (NEB),
Xanthomonas campestris pv. campestris (ATCC33913), Xanthomonas campestris
pv. vesicatoria (ATCC35937), Pseudomonas aeruginosa (Schroeter) Migula
(ATCC 25102), Vibrio cholerae 0395 (donation from Dr. Michael J. Mahan,
University of California, Santa Barbara, CA), M13KE phage (NEB), M13-NotI-
Kan construct (12), sodium chloride (NaCl) (99%; Fisher BioReagents), tryp-
tone (99%; Fisher BioReagents), yeast extract (99%; Fisher BioReagents),
E. coli ER2738 (NEB), fluorescein-5-maleimide (97%; TCI), N-succinimidyl-S-
acetylthiopropionate (SATP) (Thermo Fisher Scientific), hydroxylamine hy-
drochloride (99%; Sigma), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide
hydrochloride (EDC) (99.9%; Sigma), N-hydroxysuccinimide (NHS) (98%;
Sigma), mouse monoclonal anti-E. coli LPS antibody ([2D7/1] ab35654;
Abcam), 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF)
(Invitrogen), 5-bromosalicylic acid (5-BAA) (>98.0%; TCI), SYTO 9, PI (Thermo
Fisher Scientific), BODIPY C10 (donation from Dr. M. Kuimova from Imperial
College London, London, UK), poly(ethylene glycol) (PEG-8000; Sigma), di-
alysis kit (MWCO 3500 Da; Spectrum Labs), tetracycline (98%; Fisher Scien-
tific), kanamycin sulfate (98%; Fisher Scientific), ampicillin (98%; Fisher
Scientific), isopropyl β-D-1-thiogalactopyranoside (IPTG) (99%; Fisher Scien-
tific), Mix & Go competent cells (Zymo Research), QIAprep Spin Miniprep Kit
(Qiagen), QIAquick Gel Extraction Kit (Qiagen), KpnI-HF/NotI-HF restriction
enzyme and T4 DNA ligase (NEB), and thiol-PEG-acid (HOOC-PEG-SH; PEG
average Mn 5,000; Sigma).
Chimeric Phages. The construction of the chimeric phages used here [M13-
g3p(CTXϕ), M13-g3p(Pf1), M13-g3p(ϕLf), M13-g3p(ϕXv), and M13-g3p(If1)]
was previously reported (31). Phages were propagated according to stan-
dard protocols. Phage concentrations were quantified by real-time PCR as
previously described (31). See SI Appendix for more details.
Thiol Functionalization of Phages. Phages were treated with SATP for chemical
modification of accessible amine groups of the capsid based on a known
protocol (56). See SI Appendix for more details.
Synthesis of AuNRs. The AuNRs were synthesized through a modified method
by Murray and coworkers (34). See SI Appendix for more details.
Preparation of Phage–AuNR Bioconjugates. Conjugation of thiolated phage
with AuNRs was conducted based on a known bioconjugation method (39).
Fig. 8. Confocal microscopy (single representative section; Left) and FLIM
(Right) images of P. aeruginosa biofilm on MDCKII cells, stained with the
fluorescent molecular rotor BODIPY C10, before (A and B) and after (C and
D) treatment with M13-g3p(Pf1)–AuNRs and 10 min of NIR irradiation.
Bacterial cells appear as bright green (A and C) or cyan/blue (B and D) spots.
False color scale (B and D) represents fluorescence lifetime in nanoseconds.
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The AuNRs were resuspended in Tris buffer (50 mM, pH 3). Two hundred
microliters of thiolated phage (1 × 1011 pfu/mL) was added dropwise to 1-mL
AuNRs solution (6.8 nM). The suspension was incubated at room tempera-
ture for 2 h under moderate rotation. The phage–AuNR conjugates were
purified by repeated centrifugation/resuspension cycles (8,000 rpm for 30 min,
resuspension in 1 mL of water). The reaction was monitored by UV-vis
spectrophotometer (Shimadzu UV-1800) and Zetasizer APS (Malvern) to
follow changes of LSPR and zeta potential. The trace amount of residual
CTAB was further exchanged with HOOC-PEG-SH (2.0 μM) under the same
conditions for 24 h. The phage–AuNR bioconjugates were purified by cen-
trifugation and resuspended in 200 μL of water.
Visualization of Binding of M13KE–AuNR to E. coli. 1011M13KE–AuNR bioconjugates
(i.e., containing 1011 M13KE phages) were incubated with 2 mg/mL fluorescein-
5-maleimide in 1 mL of PBS buffer (pH 7.0) with gentle stirring at room tem-
perature overnight. The free dye was removed by extensive dialysis (MWCO
3,500 Da) in 500 mL of PBS buffer (pH 7.0), and bioconjugates were concen-
trated by ultrafiltration to ∼200 μL with an Amicon Ultra-4 10000 filter.
The M13KE–AuNR bioconjugates were incubated with 1 mL of Top 10F′
cells expressing cyan fluorescent protein at an optical density ∼0.6 for 30
min at room temperature (12). Free bioconjugates were removed by
centrifugation at 5,000 rpm and discarding the supernatant. The pellet
was washed by PBS buffer twice and resuspended in 1 mL of PBS buffer for
microscopy. The fluorescence images were recorded on a Leica SP8 confocal
microscope (Leica), with excitation at 405 nm.
Detection of Bacteria with Phage–AuNR. Bacterial cells (strains of E. coli, V.
cholerae, P. aeruginosa, and X. campestris listed above) were grown in liquid
culture and cell concentrations estimated by optical density as previously
described (31) (SI Appendix, Methods). The cells were collected by centrifu-
gation and resuspended in MilliQ water at the desired concentrations. Fifty
microliters of bacterial solution was added into 100 μL of phage–AuNR
bioconjugate solution (∼1011 phage particles per mL) in 1.5-mL tubes. The
absorbance of the solutions was recorded by UV-vis spectroscopy (Shimadzu
UV-1800) after a 30-min incubation at room temperature. The specificity
of detection was tested by adding a different bacterial species or strain
from the host of the phage source of the g3p-N homolog (Table 1), or by
adding a mixture of host cells [E. coli (F+), V. cholerae 0395, E. coli (I+),
X. campestris (pv campestris), X. campestris (pv vesicatoria), and P. aeruginosa]
for the assay.
Photothermal Lysis of Bacteria with Phage–AuNRs. To test thermolysis in
aqueous solution, the mixture of bacterial solution and phage–AuNRs
(1011 phages, and 106 cells in 1 mL solution) was irradiated for various time
periods (0 to 10 min) using an 808-nm diode laser (3.0 W/cm2; Q-BAIHE
Company) ∼8 cm from the top of the solution. After irradiation, a 10-μL
aliquot of the resulting solution was diluted into PBS buffer (0.1 M, pH 7.4)
to a ratio of 1:1,000 and cultured on plates for colony counting using
ImageJ. X. campestris (pv campestris) and X. campestris (pv vesicatoria) were
cultured on YPD agar plates with no antibiotics; the other cells were cultured
on LB plates. E. coli ER2738 was cultured on LB plates containing 10 μg/mL
tetracycline. The E. coli strains expressing cyan or citrine fluorescent proteins
(12) were cultured on LB plates containing 1 mM IPTG and 100 μg/mL
ampicillin.
To test thermolysis of a P. aeruginosa biofilm grown on solid support, the
biofilm was prepared using a protocol modified from the literature (41). A
single colony of P. aeruginosa was selected and grown in LB overnight at
37 °C in a shaker incubator. The overnight culture was diluted 100-fold into
fresh medium. One hundred fifty microliters of the dilution was added to
Lab-Tek plates (culture area, 0.7 cm2) and incubated overnight at 37 °C.
After incubation, the liquid was removed by turning the plate over and
shaking out the liquid. The remaining biofilm was washed by submerging
the plate in a small tub of water and shaking out water twice. Three hun-
dred microliters of M13-g3p(Pf1)–AuNR bioconjugates (1013 phages per mL)
were added into the biofilm and incubated for 30 min. Unbound bio-
conjugates in suspension were removed by pipetting. The biofilm was irra-
diated with the NIR laser for 10 min as described above. Cell viability was
studied by growing the resuspended bacteria on LB plates (1 μL of cell sus-
pension was diluted in 1 mL of PBS buffer, and 5 μL of the dilution was
plated onto LB plates) for colony counting, and by confocal microscopy with
live/dead cell viability staining with SYTO9 and PI.
To test thermolysis of a P. aeruginosa biofilm grown on mammalian ep-
ithelial cells, wild-type MDCKII epithelial cells in suspension were seeded at
5.0 × 104 cells per well in eight-well chamber slide Lab-Tek plates and grown
to confluency. Dulbecco’s modified Eagle’s medium (DMEM) (Thermo Fisher;
11885076) was supplemented with 10% FBS (Thermo Fisher; 10437036) and
1% penicillin–streptomycin (P/S) (Thermo Fisher; 15140122), and kept in an
incubator at 37 °C with 5% CO2. After 48 h, the culture medium was re-
moved, and the cells were washed twice with PBS buffer to remove traces of
P/S. The biofilm of P. aeruginosa was cultured on the top of the MDCKII
epithelial cells in 15 mM Hepes buffer (pH 7 with DMEM and 10% FBS) as
described above. Planktonic cells were removed from the biofilm by careful
pipetting. Incubation with M13-g3p(Pf1)–AuNR (1013 phages per mL) and
NIR irradiation of the bacterial cells was performed as described above. Cell
viability of the MDCKII cells was assayed by the PrestoBlue cell viability assay,
and bacterial and mammalian cells were assessed by confocal microscopy
with live/dead cell viability staining with SYTO9 and PI.
Cytotoxicity of Phage and Phage–AuNR. The PrestoBlue cell viability assay was
performed according to the manufacturer’s protocol (Invitrogen). MDCKII
epithelial cells were cultured to confluency in a 96-well microtiter plate as
described above. After 24 h, the medium was replaced by 180 μL of fresh
DMEM (containing 10% FBS) with 20 μL of samples of various concentrations
of M13KE phage or phage–AuNR bioconjugates in PBS buffer. The cells were
incubated for another 48 h, and the medium was replaced by 90 μL of fresh
medium, mixed with 10 μL of PrestoBlue. The cells were incubated at 37 °C
for 30 min, and fluorescence signals were measured on a TECAN infinite 200
Pro plate reader (TECAN). The excitation wavelength was 560 nm (bandwidth,
9 nm), and the emission wavelength was 600 nm (bandwidth, 20 nm). Similar
results were obtained using a 1-h incubation time. The cell viability was
expressed as a percentage relative to the control cells (MDCKII cells incubated
with PBS buffer with no phages or phage–AuNR under the same conditions).
Temperature Measurement of Cells Using BCECF. To measure the temperature
of suspended cells during thermolysis, E. coli ER2738 cells attached to the
M13KE–AuNR bioconjugates (prepared as described above) were incubated
with 10 μM BCECF solution at room temperature for 20 min. The free dye was
removed by centrifugation. The cells were washed three times and resus-
pended in PBS buffer (0.1 M, pH 7.4). The bulk fluorescence of BCECF (λex = 490
nm, λem = 500 to 600 nm) in the sample at room temperature was determined
using a Fluoromax-4 spectrofluorometer (Horiba). The presence of AuNRs did
not affect the observed spectrum of BCECF (SI Appendix, Fig. S9E). A standard
solution of BCECF (0.15 μM in PBS buffer) was prepared to match the observed
bulk fluorescence at room temperature. The fluorescence spectrum of the
standard BCECF solution was measured at varying temperatures using a Peltier-
based cuvette holder (Horiba) to construct a standard curve. The fluorescence
of the E. coli–phage–AuNR suspension was recorded simultaneously with laser
irradiation from above the sample to induce thermolysis.
To estimate the temperature of cells in a biofilm during thermolysis, a
calibration curve was first obtained by recording fluorescence images of a
biofilm stained with BCECF at different temperatures (from 25 to 90 °C) using
a Lauda Eco RE415 Silver cooling thermostat system (LAUDA-Brinkmann)
with a confocal microscope (excitation at 488 nm; TCS SP8; Leica Micro-
systems). The fluorescence intensities were calculated using ImageJ to obtain
the calibration curve between intensity vs. temperature. Cells were identi-
fied from background by thresholding and intensities recorded from the
“Analyze Particles” tool in ImageJ. Threshold settings were kept identical
between images. Between measurements, the microscope laser was shut
down, and the sample was covered with aluminum foil to reduce photo-
bleaching while the temperature was adjusted. A P. aeruginosa biofilm
was incubated with M13-g3p(Pf1)–AuNR bioconjugates and stained by
BCECF as described above. The free dye was removed by pipetting off the
liquid phase and washing three times with PBS buffer. The biofilm was
irradiated by NIR light for 10 min as described above, and a fluorescence
image was taken immediately.
Viscosity of Cell Membranes Measured by Molecular Rotor BODIPY C10. The
viscosity of mammalian and bacterial cell membranes during thermolysis was
measured by staining the biofilm with BODIPY C10 (incubation with 10 μM
BODIPY C10 at 37 °C for 20 min followed by replacement of DMEM)
and measuring by FLIM before and after NIR laser irradiation (de-
scribed above). Fluorescence lifetime images were recorded using a time-
correlated single-photon counting card (Leica Falcon FLIM). Imaging was
achieved using a confocal microscope (TCS SP8; Leica Microsystems) with a
Leica SuperK white light laser, which provided pulsed excitation permit-
ting time-resolved fluorescence imaging. The excitation wavelength used
was 488 nm. The data were analyzed by LAS X FLIM/FCS software (Leica
Falcon FLIM). The bacteria were identified manually by morphology of
the cells in confocal microscope images. The viscosities were calculated
from FLIM data according to the following viscosity-lifetime calibration
Peng et al. PNAS | January 28, 2020 | vol. 117 | no. 4 | 1959
A
PP
LI
ED
BI
O
LO
G
IC
A
L
SC
IE
N
CE
S
CH
EM
IS
TR
Y
equation, which was obtained by measuring the fluorescence lifetime of
BODIPY C10 in different solutions of methanol/glycerol mixtures with
known viscosities (43):
logV =
log T + 0.75614
0.4569
. [1]
Here, V is viscosity (in centipoises), and T is fluorescence lifetime (in
nanoseconds).
Concentration of AuNRs. Single-particle ICP-MS was performed with an
Agilent 7900 ICP-MS (Santa Clara) todetermine the concentration of theAuNRs.
The phage–AuNR bioconjugates were incubated with 5%nitric acid for a week
to degrade the virus before the measurement. The analysis was carried out in a
time-resolved analysis mode with an integration time of 100 μs per point and
no settling time between measurements. The data analysis was conducted
with the Agilent ICP-MS MassHunter software (version C.01.04 Build 544.3) via
single-nanoparticle application module.
TEM. TEM was performed on a Tecnai FEI G2 Sphera microscope (Materials
Research Laboratory [MRL], University of California, Santa Barbara) as pre-
viously described (31). M13KE–AuNR samples were prepared as described
above (Methods, Visualization of Binding of M13KE–AuNR to E. coli). The
AuNR size was calculated by measuring 200 AuNRs.
Zeta Potential Measurements. Zeta potentials were measured by using a
Malvern Zetasizer Nano ZSP operating a 4 mW He–Ne laser at 633 nm as
previously described (31). Data from three or more individual samples were
averaged, and each sample was measured five times (10 runs each).
See SI Appendix, Methods for description of additional optical charac-
terization, synthesis of AuNRs, colocalization analysis, antibody–AuNR experi-
ments, chimeric phages, phage and bacterial propagation, and EPS quantitation.
Data Availability. All data are included in the manuscript and SI Appendix.
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